1. NOACs, AF, and PCI: What Do the Latest Data Suggest?

3. NOACs for Patients With AF

4. Case: Patient With STEMI

5. Case: Management of Antithrombotic Therapy in the Acute Setting

6. Case: Management of Postdischarge Antithrombotic Therapy

7. Triple Therapy: Factors to Consider

8. Antithrombotic Management of Patients With AF Undergoing PCI

9. Danish Registry Study of Patients With AF Risk of Bleeding With Antithrombotic Therapy

10. Danish Registry Study of Patients With MI Risk of Bleeding With Antithrombotic Therapy

11. Danish Registry Study of Patients With MI Annual Incidence of Bleeding

12. WOEST Trial Study Design

13. WOEST Trial Bleeding Events

14. WOEST Trial Death, MI, Stroke, Target-Vessel Revascularization, and Stent Thrombosis

15. PIONEER AF-PCI Study Design

16. PIONEER AF-PCI Clinically Significant Bleeding

17. PIONEER AF-PCI ISTH and GUSTO Bleeding

18. PIONEER AF-PCI MACE (All Participants)

19. PIONEER AF-PCI All-Cause Rehospitalization

20. Implications of PIONEER Antithrombotic Therapy Postdischarge

21. Ongoing Antithrombotic Trials With NOACs

22. Summary

23. Abbreviations

24. Abbreviations (cont)